Literature DB >> 11009208

Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.

S Aime1, B Bergamasco, M Casu, G Digilio, M Fasano, S Giraudo, L Lopiano.   

Abstract

Neuromelanin is a dark brown pigment suspected of being involved in the pathogenesis of Parkinson's disease. This pigment can be isolated from normal human substantia nigra by a procedure that includes an extensive proteolytic treatment. In this study we used such a procedure to extract the neuromelanin pigment from a pool of substantia nigra from patients affected by Parkinson's disease. 13C Cross polarization magic angle spinning nuclear magnetic resonance spectroscopy and electron paramagnetic resonance spectroscopy were used to characterize the solid residue obtained from the extraction procedure. We found that the pigment extracted from the substantia nigra of parkinsonian patients was mainly composed of highly cross-linked, protease-resistant, lipo-proteic material, whereas the neuromelanin macromolecule appears to be only a minor component of this extract. A synthetic model of melanoprotein has been prepared by enzymatic oxidation of dopamine in the presence of albumin. Once it has undergone the same proteolytic treatment, this model system yields a 13C-NMR spectrum which is similar to that observed for the parkinsonian midbrain extract. These results are consistent with the view that oxidative stress has a relevant role in the pathogenesis of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009208     DOI: 10.1002/1531-8257(200009)15:5<977::aid-mds1032>3.0.co;2-q

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Authors:  M Fasano; B Bergamasco; L Lopiano
Journal:  J Neural Transm (Vienna)       Date:  2006-05-12       Impact factor: 3.575

2.  Investigation of the lipid component of neuromelanin.

Authors:  H Fedorow; R Pickford; E Kettle; M Cartwright; G M Halliday; M Gerlach; P Riederer; B Garner; K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-05-26       Impact factor: 3.575

3.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

4.  Evidence for specific phases in the development of human neuromelanin.

Authors:  G M Halliday; H Fedorow; C H Rickert; M Gerlach; P Riederer; K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

5.  Using solid-state NMR to monitor the molecular consequences of Cryptococcus neoformans melanization with different catecholamine precursors.

Authors:  Subhasish Chatterjee; Rafael Prados-Rosales; Susana Frases; Boris Itin; Arturo Casadevall; Ruth E Stark
Journal:  Biochemistry       Date:  2012-07-25       Impact factor: 3.162

6.  Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Authors:  Emanuele Ferrari; Mireille Engelen; Enrico Monzani; Michela Sturini; Stefania Girotto; Luigi Bubacco; Luigi Zecca; Luigi Casella
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

Review 7.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 8.  Tailoring NMR experiments for structural characterization of amorphous biological solids: A practical guide.

Authors:  John E Kelly; Christine Chrissian; Ruth E Stark
Journal:  Solid State Nucl Magn Reson       Date:  2020-08-27       Impact factor: 2.293

9.  Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure.

Authors:  Mireille Engelen; Renzo Vanna; Chiara Bellei; Fabio A Zucca; Kazumasa Wakamatsu; Enrico Monzani; Shosuke Ito; Luigi Casella; Luigi Zecca
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

Review 10.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Authors:  Manfred Gerlach; Kay L Double; Dorit Ben-Shachar; Luigi Zecca; Moussa B H Youdim; Peter Riederer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.